Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Return on Invested Capital (2019)

Serina Therapeutics' Return on Invested Capital history spans 1 years, with the latest figure at 3.2% for Q4 2019.

  • For Q4 2019, Return on Invested Capital changed N/A year-over-year to 3.2%; the TTM value through Dec 2019 reached 3.2%, changed N/A, while the annual FY2020 figure was 8.11%, 1041.0% up from the prior year.
  • Return on Invested Capital for Q4 2019 was 3.2% at Serina Therapeutics.
  • Across five years, Return on Invested Capital topped out at 3.2% in Q4 2019 and bottomed at 3.2% in Q4 2019.